StockData

Translational Development Acquisition Corp. (TDAC) stock

TDACNasdaqBlank ChecksFiscal year ends December 31Also trades as TDACU, TDACW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$10.87+0.01 (+0.09%)

Close on Nov 17, 2026Market cap $209.89MP/E –Yield –

Translational Development Acquisition cash

Cash and short-term investments held at the end of each period.

Translational Development Acquisition's cash was $85.88K at Jun 30, 2026. For fiscal 2025 it was $29.79K, down 93.2% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$29.79K-93.2%
FY2024Dec 31, 2024$438.17K+21581.0%
FY2023Dec 31, 2023$2.02K-9.2%
FY2022Dec 31, 2022$2.23K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$85.88K+143.6%
Q1 FY2026Mar 31, 2026$24.63K-88.1%
Q4 FY2025Dec 31, 2025$29.79K-93.2%
Q3 FY2025Sep 30, 2025$47.15K-79.0%
Q2 FY2025Jun 30, 2025$35.26K-51.0%
Q1 FY2025Mar 31, 2025$206.60K+10122.7%
Q4 FY2024Dec 31, 2024$438.17K+19593.2%
Q3 FY2024Sep 30, 2024$224.04K–
Q2 FY2024Jun 30, 2024$72.02K–
Q4 FY2023Dec 31, 2023$2.02K–
Q4 FY2022Dec 31, 2022$2.23K–

More Translational Development Acquisition figures

See a number that looks wrong?